Home > Financial Ratios > DR REDDYS LABORATORIES

DR REDDYS LABORATORIES
Core EBITDA Growth

    Back to All Ratios
DR REDDYS LABORATORIES is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for DR REDDYS LABORATORIES
Please provide your vote to see the results

DR REDDYS LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -19.009.2619.2274.142.18

What is the latest Core EBITDA Growth ratio of DR REDDYS LABORATORIES ?

The latest Core EBITDA Growth ratio of DR REDDYS LABORATORIES is -19.00 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-19.00
Mar20259.26
Mar202419.22
Mar202374.14
Mar20222.18

How is Core EBITDA Growth of DR REDDYS LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2026 -19
Negative
Mar2025 9.26
-51.82
Mar2024 19.22
-74.08
Mar2023 74.14
3,300.92
Mar2022 2.18 -

Other Financial Ratios of DR REDDYS LABORATORIES


Compare Core EBITDA Growth ratio of peers of DR REDDYS LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
DR REDDYS LABORATORIES ₹102,651.4 Cr -3.2% -3.9% -3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,458.0 Cr 0.7% 8.1% 16% Stock Analytics
DIVIS LABORATORIES ₹193,383.0 Cr 7% 10.2% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹169,829.0 Cr 2.5% 11.3% 49.6% Stock Analytics
CIPLA ₹116,164.0 Cr -0.3% 4.1% -3.3% Stock Analytics
MANKIND PHARMA ₹105,174.0 Cr 0.6% 7% 4.1% Stock Analytics


DR REDDYS LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
DR REDDYS LABORATORIES

-3.2%

-3.9%

-3%

SENSEX

0.9%

2.2%

-7.5%


You may also like the below Video Courses